Topical antibiotics to reduce the risk of endophthalmitis after intravitreal injection?
Ziemssen
Focke
F
Bartz-Schmidt
Karl Ulrich
KU
D000287:Administration, Topical; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D009877:Endophthalmitis / Q000209:etiology / Q000517:prevention & control*; D015818:Eye Infections, Bacterial / Q000209:etiology / Q000517:prevention & control*; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D008268:Macular Degeneration / Q000188:drug therapy; D012307:Risk Factors; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000900:Anti-Bacterial Agents; D005938:Glucocorticoids